Yan Feng

This inventor holds 23 USPTO granted patents and 13 published patent applications, plus 3 CIPO patents and 6 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Theracos, Inc., Columbia University, Fujian Haixi Pharmaceuticals Co., Ltd. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yan Feng. Retrieved from https://idiyas.com/inventor/yan-feng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 (Patent Applications = 13)

% Patents Active = 65.2

CIPO Patents = 3

EPO Patents = 6 (Patent Applications = 18)

Average Co-Inventor Count = 6.5

ph-index = 5

Forward Citations = 103(Granted Patents)

Location History:

Ridgefield, NJ (US) (2015)
Shanghai, CN (2010 - 2022)
Fujian, CN (2021 - 2023)

Company Filing History:

Fujian Haixi Pharmaceuticals Co., Ltd

patents

4. 1 out of 4,804

Dow Global Technolgoies LLC

patents

5. 1 out of 2

European Organisation for Astronomical Research in the Southern Hemisphere

patents

6. 1 out of 1

Jiaohong Biotechnology (Shanghai) Co., Ltd.

patent

7. 1 out of 1

Leadingtac Pharmaceutical (Shaoxing) Co., Ltd.

patent

8. 1 out of 1

Shanghai Meiyue Biotech Development Co., Ltd.

patent

9. 1 out of 80

Xiamen San'an Optoelectronics Co., Ltd

patents

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

Indazole Derivative

Nucleic Acid Detection

Kinase Inhibitor

Quaternary Lactam Compound

Histone Acetyltransferase

Phosphodiesterase Inhibitor

Deuterated Benzylbenzene

Narrow Band Fiber Raman

Glucose Transport Inhibitor

Spiroheterocyclic Glycosides

Benzylbenzene Derivatives

Benzylphenyl Cyclohexane

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12624019 - Indazole derivative, and preparation method therefor and use thereof (2026-05-12),

2. 12110538 - Method for detecting nucleic acid based on prokaryotic argonaute protein and application thereof (2024-10-08),

3. 11767296 - Heteroaryl compounds as kinase inhibitor (2023-09-26),

4. 11345679 - Quaternary lactam compound and pharmaceutical use thereof (2022-05-31),

5. 11247977 - Compound and use thereof in synthesis of brivaracetam intermediate and crude drug (2022-02-15),

6. 11107950 - Light emitting chip and method of producing the same (2021-08-31),

7. 11034647 - Histone acetyltransferase activators and uses thereof (2021-06-15),

8. 10640457 - Histone acetyltransferase activators and uses thereof (2020-05-05),

9. 9974782 - Phosphodiesterase inhibitors and uses thereof (2018-05-22),

10. 9969677 - Histone acetyltransferase modulators and uses thereof (2018-05-15),

11. 9422242 - Phosphodiesterase inhibitors and uses thereof (2016-08-23),

12. 9061060 - Deuterated benzylbenzene derivatives and methods of use (2015-06-23),

13. 9045584 - Oxazolidone ring containing vinyl ester resin and products therefrom (2015-06-02),

14. 8802637 - Benzylbenzene derivatives and methods of use (2014-08-12),

15. 8773752 - Narrow band fiber Raman optical amplifier (2014-07-08),

Title: Innovations and Contributions of Yan Feng in Biotechnology

Introduction

Yan Feng, based in Shanghai, China, is a prolific inventor with a remarkable portfolio comprising 19 patents. His contributions to the field of biotechnology, particularly in nucleic acid detection and therapeutic agents, stand out in his extensive career.

Latest Patents

Among his latest innovations, Yan Feng has developed a method for detecting nucleic acids based on prokaryotic Argonaute protein. This method involves a sophisticated system that includes guide ssDNA, a gene-editing enzyme (PfAgo), and a fluorescent reporter nucleic acid, paving the way for advancements in genetic research and diagnostics. Another notable patent involves a quaternary lactam compound that is utilized in the manufacture of a medicament aimed at treating and preventing thrombotic or thromboembolic disorders. These patents underscore his commitment to advancing medical science and improving therapeutic outcomes.

Career Highlights

Yan Feng has held key positions at various esteemed organizations, including Theracos, Inc. and Columbia University. His work at these institutions has facilitated significant advancements in biotechnology and healthcare, making him a respected figure in the industry.

Collaborations

Throughout his career, Yan has collaborated with talented individuals, among them Yuanwei Chen and Brian Seed, both of whom have contributed to the development of groundbreaking technologies in their respective fields. These collaborations have enabled fruitful exchanges of ideas, further enhancing innovation in his research endeavors.

Conclusion

In summary, Yan Feng's contributions to biotechnology through his numerous patents and collaborations have significantly impacted the landscape of medical research and diagnostics. His innovative approaches in nucleic acid detection and therapeutic compounds continue to inspire and drive progress in the field.

Profile summary based on public USPTO records.